The synthesis of type I collagen in osteoblastic cells is under the complex regulation of systemic and locally-produced hormones and growth factors and it is likely that other influences such as components of the extracellular matrix (ECM) are also involved in this regulation. The long-term goals of this project are investigate the regulation of alpha1(l) collagen gene expression in osteoblasts by parathyroid hormone (PTH) and insulin-like growth factors (IGFs) and to study the role of the ECM in modulating the activity of alpha1(l) collagen promoter in osteoblasts. For many of these studies, transgenic animals which harbor alpha1(l) collagen promoter DNA constructs will be used. Transgenic mice represent a unique model system in which to appreciate the hormonal regulation of collagen gene expression in a physiologic context. The inhibitory effect of PTH on alpha1(l) collagen promoter activity will be characterized in cultured calvariae from transgenic mice and the role of cyclic AMP, interleukin-6 and prostaglandins as possible mediators of this Inhibitory action will be explored. PTH-responsive loci in the alpha1(l) collagen gene will be identified by deletion mapping using stably transfected osteoblastic ROS 17/2.8 cells. To examine protein-DNA Interactions, mobility shift assays and DNase footprinting using nuclear extracts from PTH-treated cells and oligodeoxynucleotides spanning the alpha1(l) collagen promoter region of interest will be performed. Once DNA loci are identified, these regions will be altered using oligonucleotide-directed mutagenesis. Selected mutant DNA sequences will be tested for functional activity in cultured osteoblastic cells and used to generate new transgenic mouse lines for in vivo validation. The effect of IGFs on alpha1(l) collagen promoter activity in cultured calvariae from transgenic animals will be determined and the possible autocrine/paracrine role of IGFs in regulating alpha1(I) collagen promoter activity will be explored using purified inhibitory insulin-like binding protein-2, IGF neutralizing antibodies and IGF oligodeoxynucleotides. A variety experimental systems will be used to study mechanisms for the downregulation of an alpha1(l) collagen promoter construct in primary cell cultures derived from transgenic mouse calvariae and to determine the role of the ECM in regulating promoter expression. Primary cell digests from transgenic mouse calvariae will be plated on ECM substrates and mixed calvarial cells digests will be cultured in medium which promotes bone nodule formation. These studies will help elucidate molecular mechanisms by which PTH, IGF-I and ECM modulate collagen gene expression thereby providing experimental findings which will be useful in planning rationale treatment protocols for metabolic diseases of bone.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
2R01AR029850-12
Application #
3155713
Study Section
Orthopedics and Musculoskeletal Study Section (ORTH)
Project Start
1981-07-01
Project End
1996-06-30
Budget Start
1992-07-01
Budget End
1993-06-30
Support Year
12
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of Connecticut
Department
Type
Schools of Medicine
DUNS #
City
Farmington
State
CT
Country
United States
Zip Code
06030
Nervina, J M; Tetradis, S; Huang, Y-F et al. (2003) Expression of inducible cAMP early repressor is coupled to the cAMP-protein kinase A signaling pathway in osteoblasts. Bone 32:483-90
Bogdanovic, Z; Huang, Y F; Dodig, M et al. (2000) Parathyroid hormone inhibits collagen synthesis and the activity of rat col1a1 transgenes mainly by a cAMP-mediated pathway in mouse calvariae. J Cell Biochem 77:149-58
Harrison, J R; Kleinert, L M; Kelly, P L et al. (1998) Interleukin-1 represses COLIA1 promoter activity in calvarial bones of transgenic ColCAT mice in vitro and in vivo. J Bone Miner Res 13:1076-83
Tetradis, S; Nervina, J M; Nemoto, K et al. (1998) Parathyroid hormone induces expression of the inducible cAMP early repressor in osteoblastic MC3T3-E1 cells and mouse calvariae. J Bone Miner Res 13:1846-51
Huang, Y F; Harrison, J R; Lorenzo, J A et al. (1998) Parathyroid hormone induces interleukin-6 heterogeneous nuclear and messenger RNA expression in murine calvarial organ cultures. Bone 23:327-32
Tetradis, S; Pilbeam, C C; Liu, Y et al. (1997) Parathyroid hormone increases prostaglandin G/H synthase-2 transcription by a cyclic adenosine 3',5'-monophosphate-mediated pathway in murine osteoblastic MC3T3-E1 cells. Endocrinology 138:3594-600
Kream, B E; Tetradis, S; Lafrancis, D et al. (1997) Modulation of the effects of glucocorticoids on collagen synthesis in fetal rat calvariae by insulin-like growth factor binding protein-2. J Bone Miner Res 12:889-95
Tetradis, S; Pilbeam, C C; Liu, Y et al. (1996) Parathyroid hormone induces prostaglandin G/H synthase-2 expression by a cyclic adenosine 3',5'-monophosphate-mediated pathway in the murine osteoblastic cell line MC3T3-E1. Endocrinology 137:5435-40
Dodig, M; Kronenberg, M S; Bedalov, A et al. (1996) Identification of a TAAT-containing motif required for high level expression of the COL1A1 promoter in differentiated osteoblasts of transgenic mice. J Biol Chem 271:16422-9
Kream, B E; Harrison, J R; Krebsbach, P H et al. (1995) Regulation of type I collagen gene expression in bone. Connect Tissue Res 31:261-4

Showing the most recent 10 out of 23 publications